Compounds > temiverine
Page last updated: 2024-09-04

temiverine and pp242

temiverine has been researched along with pp242 in 1 studies

Compound Research Comparison

Studies
(temiverine)		Trials
(temiverine)		Recent Studies (post-2010)
(temiverine)		Studies
(pp242)		Trials
(pp242)		Recent Studies (post-2010) (pp242)
3412102098

Protein Interaction Comparison

ProteinTaxonomytemiverine (IC50)pp242 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)1.8085
Tyrosine-protein kinase ABL1Homo sapiens (human)2.502
Proto-oncogene tyrosine-protein kinase SrcGallus gallus (chicken)2.6263
Epidermal growth factor receptorHomo sapiens (human)4.4
Tyrosine-protein kinase HCKHomo sapiens (human)2.4678
Platelet-derived growth factor receptor betaHomo sapiens (human)2.6263
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)2.49
Vascular endothelial growth factor receptor 2Homo sapiens (human)2.5011
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)1.9352
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)1.174
Serine/threonine-protein kinase mTORHomo sapiens (human)1.4284
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)1.3
Ephrin type-B receptor 4Homo sapiens (human)2.7122
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)1.8292
Receptor protein-tyrosine kinase Homo sapiens (human)2.6263
Rapamycin-insensitive companion of mTORHomo sapiens (human)0.08
Regulatory-associated protein of mTORHomo sapiens (human)0.008
Target of rapamycin complex 2 subunit MAPKAP1Homo sapiens (human)0.08
Target of rapamycin complex subunit LST8Homo sapiens (human)0.044
Phosphatidylinositol 4-kinase betaHomo sapiens (human)0.408

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandrika, G; Chugh, A; Natesh, K; Ranade, D; Shastry, P1

Other Studies

1 other study(ies) available for temiverine and pp242

ArticleYear
Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.
    Scientific reports, 2016, Mar-04, Volume: 6

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Glioblastoma; Humans; Indoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Naphthyridines; Neoplasm Invasiveness; NF-kappa B; Phenylacetates; Protein Kinase C-alpha; Purines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2016